Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Front Oncol ; 3: 229, 2013 Sep 11.
Article in English | MEDLINE | ID: mdl-24062982

ABSTRACT

Melanoma is a very aggressive neoplasm with a propensity to undergo progression and invasion early in its evolution. The molecular pathways underpinning invasion in melanoma are now just beginning to be elucidated, but a clear understanding of the transition from non-invasive to invasive melanoma cells remains elusive. Microphthalmia-associated transcription factor (MITF), is thought to be a central player in melanoma biology, and it controls many aspects of the phenotypic expression of the melanocytic lineage. However, recently the paired box transcription factor PAX3 was shown to transcriptionally activate POU3F2/BRN2, leading to direct repression of MITF expression. Here we present a theory to explain melanoma phenotype switching and discuss the predictions that this theory makes. One prediction is that independent and opposing roles for MITF and PAX3 in melanoma would be expected, and we present empirical evidence supporting this: in melanoma tissues PAX3 expression occurs independently of MITF, and PAX3 does not play a key role in melanoma cell proliferation. Furthermore, we show that knockdown of PAX3 inhibits cell migration in a group of "lower MITF" melanoma cell lines, while knockdown of MITF promotes cell migration in a complementary "higher MITF" group of melanoma cell lines. Moreover, the morphological effects of knocking down PAX3 versus MITF in melanoma cells were found to differ. While these data support the notion of independent roles for MITF and PAX3, additional experiments are required to provide robust examination of the proposed genetic switch theory. Only upon clear delineation of the mechanisms associated with progression and invasion of melanoma cells will successful treatments for invasive melanoma be developed.

2.
Nephrology (Carlton) ; 17(8): 739-47, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22725947

ABSTRACT

AIM: Polycystic kidney disease (PKD) in humans involves kidney cyst expansion beginning in utero. Recessive PKD can result in end-stage renal disease (ESRD) within the first decade, whereas autosomal dominant PKD (ADPKD), caused by mutations in the PKD1 or PKD2 gene, typically leads to ESRD by the fifth decade of life. Inhibition of mTOR signalling was recently found to halt cyst formation in adult ADPKD mice. In contrast, no studies have investigated potential treatments to prevent cyst formation in utero in recessive PKD. Given that homozygous Pkd1 mutant mice exhibit cyst formation in utero, we decided to investigate whether mTOR inhibition in utero ameliorates kidney cyst formation in foetal Pkd1 homozygous mutant mice. METHODS: Pregnant Pkd1(+/-) female mice (mated with Pkd1(+/-) male mice) were treated with rapamycin from E14.5 to E17.5. Foetal kidneys were dissected, genotyped and evaluated by cyst size as well as expression of the developmental marker, Pax2. RESULTS: Numerous cysts were present in Pkd1(-/-) kidneys, which were twice the weight of wild-type kidneys. Cyst size was reduced by a third in rapamycin-treated Pkd1(-/-) kidney sections and kidney mass was reduced to near wild-type levels. However, total cyst number was not reduced compared with control embryos. Pax2 expression and kidney development were unaltered in rapamycin-treated mice but some lethality was observed in Pkd1(-/-) null embryos. CONCLUSION: Rapamycin treatment reduces cyst formation in Pkd1(-/-) mutant mice; therefore, the prevention of kidney cyst expansion in utero by mTOR inhibition is feasible. However, selective rapamycin-associated lethality limits its usefulness as a treatment in utero.


Subject(s)
Embryo, Mammalian/drug effects , Kidney/drug effects , Polycystic Kidney, Autosomal Dominant/prevention & control , Protein Kinase Inhibitors/pharmacology , Sirolimus/pharmacology , TOR Serine-Threonine Kinases/antagonists & inhibitors , TRPP Cation Channels/deficiency , Animals , Embryo, Mammalian/enzymology , Embryo, Mammalian/pathology , Feasibility Studies , Female , Gene Expression Regulation, Developmental , Genetic Predisposition to Disease , Gestational Age , Homozygote , Kidney/embryology , Kidney/enzymology , Male , Mice , Mice, Inbred C3H , Mice, Knockout , PAX2 Transcription Factor/metabolism , Phenotype , Polycystic Kidney, Autosomal Dominant/embryology , Polycystic Kidney, Autosomal Dominant/enzymology , Polycystic Kidney, Autosomal Dominant/genetics , Protein Kinase Inhibitors/toxicity , Sequence Deletion , Signal Transduction/drug effects , Sirolimus/toxicity , TOR Serine-Threonine Kinases/metabolism , TRPP Cation Channels/genetics
3.
J Reprod Dev ; 58(4): 490-500, 2012.
Article in English | MEDLINE | ID: mdl-22522229

ABSTRACT

Genomic imprinting confers allele-specific expression in less than 1% of genes, in a parent-of-origin specific fashion. In humans and mice the Peg1/Mest gene (Mest) is maternally repressed, and paternally expressed. Mest is expressed in embryogenic mesoderm-derived tissues and in adult brain, and paternal mutations in Mest lead to growth retardation and defective maternal behaviour. Despite our current understanding of mechanisms associated with the establishment of imprinting of Mest and other imprinted genes, it is unclear to what extent Mest imprinting needs to be maintained in adult tissues. Aberrations of imprinting are known to occur in certain rare syndromes, and involve either inherited mutations, or constitutive epigenetic alterations occurring soon after fertilization. Imprinting abnormalities may also occur in the aging somatic tissues of adult individuals. Here we report an occurrence of post-embryonic somatic variability of Mest allelic expression in a colony of mice where heterozygotes at the imprinted Mest locus for a mutation inherited from the father spontaneously expressed the normally silenced allele from the mother. In addition, a newly acquired ability to overcome the deficit in maternal reproductive behaviour had occurred in the mutant mice, but this appeared not to be directly linked to the Mest mutation. Our results suggest that at least one allele of Mest expression is required in the somatic tissues of adult individuals and that under certain conditions (such as in the presence of a Mest insertional mutation or in an altered genetic background), somatically acquired alterations of allelic expression at the Mest locus may occur.


Subject(s)
Brain/metabolism , Gene Expression Regulation, Developmental , Genomic Imprinting , Inheritance Patterns , Maternal Behavior , Nerve Tissue Proteins/metabolism , Proteins/metabolism , Animals , Behavior, Animal , Brain/embryology , Brain/growth & development , Crosses, Genetic , Female , Gene Silencing , Genes, Lethal , Male , Mesoderm/metabolism , Mice , Mice, 129 Strain , Mice, Mutant Strains , Mutagenesis, Insertional , Nerve Tissue Proteins/genetics , Neurons/metabolism , Proteins/genetics , Specific Pathogen-Free Organisms
4.
Melanoma Res ; 21(1): 24-34, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21164369

ABSTRACT

PAX3 and MITF are important transcriptional activators in the melanocyte lineage and PAX3 is thought to control MITF expression during normal melanocyte differentiation. However, it is not clear whether this is still true in melanoma and whether the effects of knockdown of PAX3 on the inhibition of melanoma growth or survival are by its regulation of MITF. By western blot and quantitative real-time reverse transcription-PCR, we investigated the relationship between PAX3 and MITF expression in 27 metastatic melanoma and one immortalized melanocyte cell lines. All lines were found to express both PAX3 and MITF proteins but levels varied by 15 fold and more than 100 fold, respectively. The expression of PAX3 protein was correlated with that of MITF (r=0.75; P<0.001) but the expression of PAX3 protein and MITF mRNA was not. Immunofluorescence microscopy showed that individual cells expressed widely differing relative amounts of PAX3 and MITF protein. By MTT cell proliferation and flow cytometry assays, both MITF and PAX3 proteins seemed to be functional, as knockdown with siRNA led to reduced proliferation and induction of apoptosis. However, knockdown of PAX3 with small interfering RNA did not decrease MITF expression and vice versa. In one cell line (NZM15), silencing of PAX3 induced terminal differentiation whereas silencing of MITF induced expression of FOXD3, a repressor of melanogenesis. The results suggest that the melanoma lines used in this study show considerable phenotypic variation of expression of these two transcriptional activators and reflect a deregulation of the developmental process operating in the genesis of the melanocyte lineage, and that they probably function independently to enhance the survival of melanoma cells.


Subject(s)
Gene Expression Regulation, Neoplastic , Gene Silencing , Melanoma/metabolism , Microphthalmia-Associated Transcription Factor/metabolism , Paired Box Transcription Factors/metabolism , Skin Neoplasms/metabolism , Apoptosis , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Cell Survival , Flow Cytometry , Humans , Melanocytes/metabolism , Neoplasm Metastasis , PAX3 Transcription Factor , Phenotype , RNA, Small Interfering/metabolism
5.
Immunol Cell Biol ; 88(6): 651-7, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20231853

ABSTRACT

DNA-based vaccines, alone or in combination with other sub-unit vaccination regimes, represent an alternative to live mycobacterial vaccines for protective immunization against tuberculosis. Here, we have used a murine immunization or Mycobacterium bovis aerosol challenge model to assess the immunogenicity and protective efficacy of mycobacterial DNA vaccines. Mice that received immunization with DNA constructs encoding M. bovis antigen 85A (Ag85-A) and arget(ESAT-6) produced measurable interferon-gamma (IFN-gamma) responses to CD4(+) T-cell epitope-peptide recall antigens in vitro. The magnitude of these responses was enhanced by co-delivery of a construct encoding murine cytokines (macrophage inhibitory protein (MIP)-1 alpha or interleukin(IL)-7), although they did not the match responses observed in mice that received Bacille Calmette-Guerin(BCG) immunisation. In contrast, DNA priming followed by boosting with modified vaccinia Ankara (MVA) vaccine (expressing M. tuberculosis Ag85-A) invoked higher IFN-gamma levels, with the most immunogenic regime of Ag85 or ESAT or IL-7 prime followed by MVA boost being of commensurate immunogenicity to BCG. Despite this, neither DNA alone nor DNA-prime or MVA boost regimes conferred measurable protection against aerosol challenge with virulent M. bovis. These data highlight both the promise and the shortcomings of new generation subunit tuberculosis vaccines, with particular emphasis on their potential as vaccines against M. bovis.


Subject(s)
CD4-Positive T-Lymphocytes/metabolism , Mycobacterium bovis/immunology , Tuberculosis Vaccines , Tuberculosis, Pulmonary/prevention & control , Viral Vaccines , Acyltransferases/genetics , Acyltransferases/metabolism , Animals , Antigens, Bacterial/genetics , Antigens, Bacterial/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/pathology , Chemokine CCL3/genetics , Chemokine CCL3/metabolism , Epitopes, T-Lymphocyte/immunology , Epitopes, T-Lymphocyte/metabolism , Immunization, Secondary , Interferon-gamma/metabolism , Interleukin-7/genetics , Interleukin-7/metabolism , Mice , Mice, Inbred BALB C , Mycobacterium bovis/pathogenicity , Plasmids/genetics , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology , Vaccines, DNA
6.
Immunol Cell Biol ; 88(1): 95-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19652662

ABSTRACT

Animal models indicate that exposure to environmental strains of mycobacteria can modulate immune responses and influence the effectiveness of live mycobacterial vaccines. Here, we describe that between the two recently reported Mycobacterium avium isolates, strain WAg 206 (but not strain WAg 207) interferes with human monocyte-derived dendritic cell (MDDC) activation. WAg 206, unlike WAg 207, did not elicit inflammatory cytokine production (TNFalpha, IL-1beta, IL-12) or costimulatory molecule expression (HLA-DR, CD83, CD80, CD86) by human MDDCs in vitro. These data highlight the potential for environmental mycobacteria to modulate immune responses in humans, and suggest a mechanism by which earlier exposure to such microbes may compromise the efficacy of live mycobacterial vaccines, as has been observed in some human BCG vaccine trials.


Subject(s)
Dendritic Cells/immunology , Mycobacterium avium/immunology , Antigens, CD/immunology , Cell Differentiation , Cells, Cultured , Cytokines/immunology , Dendritic Cells/cytology , HLA Antigens/immunology , Humans , Monocytes/cytology , Monocytes/immunology , Mycobacterium avium/growth & development
7.
PLoS One ; 4(12): e8461, 2009 Dec 24.
Article in English | MEDLINE | ID: mdl-20041153

ABSTRACT

BACKGROUND: We are investigating the molecular basis of melanoma by defining genomic characteristics that correlate with tumour phenotype in a novel panel of metastatic melanoma cell lines. The aim of this study is to identify new prognostic markers and therapeutic targets that might aid clinical cancer diagnosis and management. PRINCIPAL FINDINGS: Global transcript profiling identified a signature featuring decreased expression of developmental and lineage specification genes including MITF, EDNRB, DCT, and TYR, and increased expression of genes involved in interaction with the extracellular environment, such as PLAUR, VCAN, and HIF1a. Migration assays showed that the gene signature correlated with the invasive potential of the cell lines, and external validation by using publicly available data indicated that tumours with the invasive gene signature were less melanocytic and may be more aggressive. The invasion signature could be detected in both primary and metastatic tumours suggesting that gene expression conferring increased invasive potential in melanoma may occur independently of tumour stage. CONCLUSIONS: Our data supports the hypothesis that differential developmental gene expression may drive invasive potential in metastatic melanoma, and that melanoma heterogeneity may be explained by the differing capacity of melanoma cells to both withstand decreased expression of lineage specification genes and to respond to the tumour microenvironment. The invasion signature may provide new possibilities for predicting which primary tumours are more likely to metastasize, and which metastatic tumours might show a more aggressive clinical course.


Subject(s)
Gene Expression Profiling , Melanoma/genetics , Melanoma/pathology , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Cell Line, Tumor , Cell Movement/genetics , Gene Dosage/genetics , Gene Expression Regulation, Neoplastic , Genes, Neoplasm/genetics , Genome, Human/genetics , Humans , Models, Genetic , Neoplasm Invasiveness/genetics , Neoplasm Invasiveness/pathology , Neoplasm Metastasis , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reproducibility of Results
8.
Infect Immun ; 75(6): 2833-40, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17371857

ABSTRACT

Prior exposure of a vaccinee to certain species of environmental mycobacteria can prime the immune system against common mycobacterial antigens, which can in turn reduce the subsequent efficacy of live attenuated mycobacterial vaccines (such as Mycobacterium bovis BCG), in both human and livestock vaccination programs. In this study, two strains of Mycobacterium avium, both isolated from New Zealand livestock, were investigated to determine their growth characteristics and effects on the immune system in murine models. Markedly different effects on the immune system were observed; an IS901-negative strain (WAg 207) induced significant up-regulation of cell surface activation markers (major histocompatibility complex II, CD80, and CD86) on in vitro-derived dendritic cells and induced the release of proinflammatory monokines (interleukin-1beta [IL-1beta], IL-6, and tumor necrosis factor alpha) in dendritic cell-macrophage cocultures following direct in vitro contact of cells with bacteria. In contrast, an IS901-positive strain (WAg 206) had none of these effects. When mice were exposed to M. avium via oral infection prior to BCG parenteral immunization, both strains were shown to be capable of decreasing subsequent antigen-stimulated gamma interferon secretion by splenic lymphocytes, although this effect was more significant for strain WAg 206. Both strains also induced a mycobacterial antigen-specific serological response in M. avium-sensitized and BCG-immunized mice; this response was greater in WAg 206-sensitized mice, and there was a predominance of immunoglobulin G1 antibody. The down-regulation of IFN-gamma responses and the up-regulation of antibody responses are characteristic of a switch to a type 2 immune response. The different results may be linked to the inherent growth characteristics of the two strains, since WAg 206 was shown to grow slowly in murine macrophages in vitro and to cause a persistent systemic infection following infection in vivo, while WAg 207 grew fast and did not persist in mice. The implications of these findings for BCG vaccination protocols are discussed.


Subject(s)
Antibodies, Bacterial/biosynthesis , Antigens, Bacterial/immunology , BCG Vaccine/immunology , Mycobacterium avium/immunology , Mycobacterium bovis/immunology , Tuberculosis/prevention & control , Animals , Cross Reactions , Environmental Microbiology , Humans , Mice , Mice, Inbred BALB C , Tuberculosis/immunology , Vaccination , Vaccines, DNA/immunology
9.
Vaccine ; 24(21): 4471-4, 2006 May 22.
Article in English | MEDLINE | ID: mdl-16140432

ABSTRACT

Unlike intramuscular injection, gene gun delivery of DNA drives a strong type 2 response. In an effort to counter this, we have genetically fused the type 1 cytokines, IL-12 and IL-23, to the hemagglutinin (HA) gene from influenza APR/8/34, and delivered these DNA constructs to Balb/c mice. Gene gun delivery of the HA gene was able to induce antibody production by all vaccinated mice. Linking of IL-12 caused almost complete suppression of immune responses whereas mice vaccinated with IL-23HA showed long-lived IgG1 antibody levels. Splenocytes from IL-23HA vaccinated mice also tended to produce more IL-5 and IFNgamma after restimulation in vitro than splenocytes from HA vaccinated mice. While codelivery of IL-23 did not change the type of immune response it may increase its longevity following vaccination.


Subject(s)
Biolistics , Interleukin-12/immunology , Interleukin-23/immunology , Th1 Cells/immunology , Vaccines, DNA/immunology , Animals , Antibodies, Viral/biosynthesis , Base Sequence , Cell Line , DNA Primers , Enzyme-Linked Immunosorbent Assay , Humans , Mice , Orthomyxoviridae/immunology , Vaccines, DNA/administration & dosage
10.
J Nutr ; 135(11): 2651-6, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16251625

ABSTRACT

Antigen-presenting cells (APCs) are multifunctional components of the immune defense system. In this study, murine APCs were used as biosensors to detect immunologically active components of bovine milk and colostrum. By measuring changes in cell surface protein markers [major histocompatibility complex II, cluster designation (CD)40, CD86] and cytokines (tumor necrosis factor-alpha and interleukin-10) associated with APC activation, we identified a number of compounds that are immunoactive. The mouse macrophage cell line MH-S offered a simple and robust target for identification of immunoactives. The assay was shown to be adaptable for measuring immunoenhancing or immunosuppressive substances. Large-scale screening of milk extracts using this bioassay has the potential to identify substances that could be developed into nutraceuticals or pharmaceutical-grade immunotherapeutics.


Subject(s)
Antigen-Presenting Cells/immunology , Milk/immunology , Animals , B7-2 Antigen/analysis , Biosensing Techniques , CD40 Antigens/analysis , Cattle , Cell Line , Colostrum/chemistry , Culture Media , Dendritic Cells , Histocompatibility Antigens Class II/analysis , Interleukin-10/analysis , Macrophage Activation , Macrophages , Mice , Mice, Inbred BALB C , Milk/chemistry , Milk Proteins , Tumor Necrosis Factor-alpha/analysis
11.
Immunol Cell Biol ; 81(3): 185-91, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12752682

ABSTRACT

A single dose vaccine formulation which induces both humoral and cell-mediated immune responses over a prolonged period would provide a potent weapon against infectious disease. We have used a water-in-oil-in-oil, solvent evaporation method for generating poly epsilon-caprolactone microparticles and tested their ability to induce an immune response against the model antigen ovalbumin. We hypothesized that the initial release of antigen from the surface of the poly epsilon-caprolactone microparticles would act as the priming dose and that the delayed release over the following months, due to diffusion from or break-down of the microparticles, would act as a boost to the immune response. Ovalbumin encapsulated in the poly epsilon-caprolactone microparticles was able to induce both antibody and cell-mediated immune responses. However our results suggest that the spontaneous release had little effect on the immune response. Despite this the response was maintained for at least 8 months following a single immunization. Both humoral and cell-mediated immune responses were induced in mice. This simple method of vaccine formulation offers a cost-efficient way to deliver antigen in a single dose to the immune system.


Subject(s)
Delayed-Action Preparations , Ovalbumin/administration & dosage , Vaccines/administration & dosage , Animals , Antibody Formation/immunology , Biodegradation, Environmental , Caproates/chemistry , Drug Carriers , Electrophoresis, Polyacrylamide Gel , Lactones/chemistry , Lymphocyte Activation/immunology , Male , Mice , Microscopy, Electron, Scanning , Ovalbumin/immunology , Particle Size , Polymers/administration & dosage , Polymers/chemistry
12.
Immunol Cell Biol ; 80(3): 209-15, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12067407

ABSTRACT

Bacillus Calmette Guerin (BCG) has been reported to show variable efficacy as a vaccine against tuberculosis. We demonstrated that the secretion of biologically active IL-2 (rBCG/IL-2),but not IL-18 (rBCG/IL-18), by BCG improves its ability to induce and maintain a strong type 1 immune response in BALB/c mice. rBCG/IL-2 induced significantly higher Ag-specific proliferative responses, high IFN-gamma production and serum titres of IgG2a 16 weeks after vaccination. This immune profile was correlated to an increased rate of clearance of non-pathogenic mycobacteria (live BCG delivered intranasally). Surprisingly, however,this strong type 1 immune profile induced no greater protective immunity against aerosol challenge with virulent Mycobacterium bovis than that induced by normal BCG (nBCG). By comparison,vaccination with rBCG/IL-18 was found to induce significantly less IFN-gamma production in splenic lymphocytes than nBCG. This impaired induction of IFN-gamma was correlated to a significantly lower protective efficacy against M. bovis challenge, as compared to nBCG. The data suggest that manipulation of the immune response to tuberculosis and tuberculosis vaccines will require a more complete understanding of the factors that are important in generating a protective immune response.


Subject(s)
BCG Vaccine/genetics , BCG Vaccine/immunology , Interleukin-18/genetics , Interleukin-2/genetics , Mycobacterium bovis/immunology , Animals , BCG Vaccine/classification , Cattle , Cells, Cultured , DNA, Recombinant/immunology , Immunoglobulin Isotypes/analysis , Interferon-gamma/analysis , Interleukin-18/biosynthesis , Interleukin-2/biosynthesis , Mice , Mice, Inbred BALB C , Mycobacterium bovis/pathogenicity , Spleen/immunology , Spleen/microbiology , Time Factors , Vaccination , Vaccines, DNA/immunology , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...